MOLBIO:NSE
Molbio Diagnostics Limited
₹1,374.00
arrow_downward
-4.46%(-64.20) 1D
Sep 15, 3:30:00 PM GMT+5:30 · INR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MOLBIO...
Open
₹1,419.70
High
₹1,419.70
Low
₹1,273.00
Mkt. cap
156.52B
Avg. vol.
0.00
Volume
3.77M
P/E ratio
93.00
52-wk high
₹1,686.80
52-wk low
₹926.35
EPS
₹14.77
No. of employees
1K
Open
₹1,419.70
High
₹1,419.70
Low
₹1,273.00
Mkt. cap
156.52B
Avg. vol.
0.00
Volume
3.77M
P/E ratio
93.00
52-wk high
₹1,686.80
52-wk low
₹926.35
EPS
₹14.77
No. of employees
1K
Profile
Molbio Diagnostics Limited is an Indian medical diagnostics company headquartered in Verna, Goa, that develops molecular diagnostic technologies. Founded in 2000, the company developed the Truenat platform, a portable real-time PCR system used to diagnose infectious diseases including tuberculosis, HIV, and hepatitis.
The Truenat platform is recognized by the World Health Organization for the initial detection of tuberculosis and rifampicin resistance. Following clinical studies, including research published in The Lancet, the technology has been adopted by national health programs in over 85 countries.
In 2025, Molbio was awarded the Kochon Prize by the Stop TB Partnership, the world's largest award for tuberculosis. Wikipedia
About Molbio Diagnostics Limited